Celecoxib/Ciprofloxacin

塞来昔布/环丙沙星

Report date: 2026/04/10 20:01:49

Base Information

Drug NameCelecoxib/Ciprofloxacin
Drug Alias NameCiprofloxacin/celecoxib(NeuroSense Therapeutics)PrimeCPrimeC-ERStabiliCCogniC
ClassificationSmall molecules > ProdrugSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionCyclooxygenase-2 inhibitorsDNA topoisomerase inhibitorsBacterial DNA gyrase inhibitors
TargetsCyclooxygenase-2Bacterial DNA gyraseDNA topoisomerase
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[4] 
CombinationsYes CiprofloxacinCelecoxib
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurosense Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNeurosense Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A